Schedule a Free Consultation: (866) 881-0403
Schedule a Free Consultation: (866) 881-0403

Patient Sues After Suffering Life-Threatening Bleed From Xarelto

Bradley/Grombacher, LLP • Oct 10, 2017

A new lawsuit has been filed against the makers of Xarelto due to allegations of dangerous side effects. The plaintiff sustained severe injuries caused by a life-threatening bleed from Xarelto after being prescribed the medication from a physician.


Xarelto is a commonly used blood thinner prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, to treat and reduce the risk of deep vein thrombosis (DVT) and pulmonary embolism, and to prevent DVT for patients undergoing hip or knee replacement surgery.


New research and adverse event reports from patients, however, show that people may suffer severe injuries caused by a  life-threatening bleed from Xarelto despite the fact that it’s marketed as a safe and modern alternative for treating the above-mentioned issues.

Xarelto has been linked to severe and uncontrollable bleeding in patients because it does not have a bleeding antidote. If a Xarelto patient begins to hemorrhage, there is very little a doctor can do to stop the bleeding.


Hundreds of lawsuits have been filed by patients who suffered a life-threatening bleed from Xarelto and from family members of patients who died from Xarelto bleeding. These lawsuits accuse the drug manufacturer of failing to properly warn physicians and patents about the risk of uncontrollable bleeding from Xarelto and that no antidote to stop the bleeding exists.


Allegations of Life-Threatening Bleed From Xarelto Emerge in New Lawsuit

Plaintiff Louise P. of Ohio is one of many who has alleged a life-threatening bleed from Xarelto in legal action against the drug’s manufacturers.

The manufacturers of the drug are accused of making an unsafe drug and marketing the medication to the medical community without a full disclosure of the risks. Furthermore, the defendants are accused of failing to carry out the proper tests in order to ensure that the medication was safe for use.


In this case, which argues that the plaintiff was ultimately the victim of a life-threatening bleed from Xarelto, the patient began taking the drug on September 1, 2015. The medication was taken through September 18, 2015. On September 13th, the patient suffered gastrointestinal bleeding believed to be tied to Xarelto use. The life-threatening bleeding from Xarelto led to a hospital stay, medical expenses, and severe permanent injuries, according to the lawsuit filed.


Xarelto inhibits thrombin, a substance necessary for blood clotting in the human body. When there is no mechanism in the body to stop blood flow, it can lead to severe or a deadly combination of medical conditions. If bleeding occurs in the upper GI tract, which is made up of the stomach, some of the small intestine, and the esophagus, bleeding can cause abdominal tenderness, vomiting blood, and stomach upset. If doctors do not intervene immediately, life-threatening injuries can occur.


More often than not, an underlying condition is exacerbated by use of Xarelto that causes gastrointestinal bleeding. The underlying conditions could include stomach ulcer bleeding, chronic acid reflux, bleeding intestinal polyps, anal fissures, or ulcerative colitis.


If left untreated, internal bleeding can develop into life-threatening complications. In the worst cases, the patient may even die from gastrointestinal bleeding if its not caught right away.


Did You Suffer a Life-Threatening Bleed From Xarelto?

If you or someone you know has suffered a life-threatening bleed from Xarelto such as a GI bleed, brain bleed or other type of internal bleeding, the lawyers at Bradley/Grombacher can help you determine your eligibility for a claim and to help you file legal action right away.

Fill out the form on this page now for a FREE case evaluation. 


By Kiley L. Grombacher 21 Jun, 2023
Bradley/Grombacher LLP
Abercrombie Clothing Lawsuit Leads to $25 Million Dollar Settlement
By Bradley/Grombacher, LLP 16 May, 2023
An Abercrombie clothing lawsuit has led to a $25 million settlement over allegations that employees were required to purchase the clothing they were selling in the store.
Join Us For The 2022 Class Action Litigation Conference!
By Marcus J. Bradley 14 Sep, 2022
The program will feature an update of Pending Cases in the 9th Circuit with some SCOTUS discussion, and several important technical issues required for bringing and defending class actions.
By Bradley/Grombacher, LLP 22 Jun, 2022
Marcus Bradley is a founder and partner at Bradley/Grombacher, LLP, and focuses much of his practice on complex consumer litigation, class actions, mass torts, product liability, personal injury, and more.
By Bradley/Grombacher, LLP 21 Jun, 2022
Kiley Grombacher is a founder and partner at Bradley/Grombacher, LLP, and focuses much of her practice in complex litigation including consumer and employment class actions, product liability, and pharmaceutical mass torts.
By Bradley/Grombacher, LLP 12 May, 2022
The Harris Martin's MDL Conference is focusing on recalled infant formula and Gardasil.
By Bradley/Grombacher, LLP 12 May, 2022
The retreat is designed for attorneys and provides 6 credit hours of continuing legal education (CLE). During the event, Attorney Grombacher will be a featured speaker presenting on PAGA: What's Next After Viking River Cruises?
By Bradley/Grombacher, LLP 23 Aug, 2021
At Bradley/Grombacher, LLP, we invite you to attend HarrisMartin’s Webinar Series: Neutrogena Sunscreen Litigation. Learn more:
By Bradley/Grombacher, LLP 17 Nov, 2020
Bradley/Grombacher Law More parents are reporting the downside of school spirit – cheerleading injuries that can be catastrophic and life altering.
By Bradley/Grombacher, LLP 18 Oct, 2020
Zoosk and its parent company have been hit with a class-action lawsuit after a May 2020 data breach by a group that calls itself the "ShinyHunters" compromised 30 million users.
More Posts
Share by: